Pacira BioSciences Ownership | Who Owns Pacira BioSciences?
Pacira BioSciences Ownership Summary
Pacira BioSciences is owned by 57.04% institutional investors, 3.21% insiders, and 39.75% retail investors. Blackrock is the largest institutional shareholder, holding 17.34% of PCRX shares. Pacer US Small Cap Cash Cows 100 ETF is the top mutual fund, with 6.65% of its assets in Pacira BioSciences shares.
PCRX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Pacira BioSciences | 57.04% | 3.21% | 39.75% |
Sector | Healthcare Stocks | 57.00% | 9.26% | 33.74% |
Industry | Specialty & Generic Drug Manufacturers Stocks | 25.54% | 11.03% | 63.43% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 8.01M | 17.34% | $229.08M |
Blackrock funding, inc. /de | 7.71M | 16.71% | $145.25M |
Vanguard group | 5.26M | 11.41% | $99.17M |
Pacer advisors | 3.26M | 7.07% | $61.47M |
D. e. shaw | 2.26M | 4.89% | $42.53M |
Renaissance | 1.99M | 4.32% | $37.54M |
State street | 1.97M | 4.26% | $37.03M |
Dimensional fund advisors lp | 1.83M | 3.97% | $34.52M |
Doma perpetual capital management | 1.75M | 3.79% | $32.93M |
Macquarie group | 1.57M | 3.39% | $44.83M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Doma perpetual capital management | 1.75M | 16.39% | $32.93M |
Sio capital management | 455.50K | 3.53% | $13.03M |
Gagnon advisors | 133.39K | 1.61% | $2.51M |
Gagnon securities | 321.74K | 1.22% | $6.06M |
Bridge city capital | 229.20K | 1.15% | $4.32M |
Pdt partners | 248.61K | 0.41% | $4.68M |
Rice hall james & associates | 260.19K | 0.27% | $4.90M |
Corton capital | 21.57K | 0.23% | $406.47K |
Outfitter financial | 13.06K | 0.20% | $246.15K |
Entrypoint capital | 23.02K | 0.18% | $433.72K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ubs group | 1.37M | 0.00% | 1.18M |
Point72 asset management | 1.08M | 0.04% | 1.08M |
Millennium management | 1.49M | 0.01% | 879.47K |
Balyasny asset management | 434.21K | 0.01% | 434.21K |
Goldman sachs group | 736.93K | 0.00% | 393.54K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Frontier capital management | - | - | -1.84M |
Pacer advisors | 3.26M | 0.13% | -1.70M |
Stephens investment management group | - | - | -1.37M |
Clearbridge investments | - | - | -1.17M |
Baillie gifford | - | - | -806.10K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Point72 asset management | 1.08M | 0.04% | 1.08M | $20.27M |
Balyasny asset management | 434.21K | 0.01% | 434.21K | $8.18M |
Hrt financial lp | 179.90K | 0.02% | 179.90K | $3.39M |
Norges bank | 127.66K | 0.00% | 127.66K | $2.41M |
J. goldman & co lp | 127.14K | 0.06% | 127.14K | $2.40M |
Sold Out
Holder | Change |
---|---|
Northwestern mutual wealth management | -1.00 |
Sjs investment consulting | -5.00 |
Prairieview partners | -5.00 |
Dinuzzo private wealth | -6.00 |
Farther finance advisors | -8.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 121 | -51.60% | 26,315,048 | -48.41% | 57 | 0.47% | 54 | -60.00% | 40 | -43.66% |
Sep 30, 2024 | 249 | -13.54% | 51,009,626 | -1.76% | 110 | 0.87% | 137 | -12.74% | 70 | -7.89% |
Jun 30, 2024 | 288 | 2.86% | 51,920,945 | 6.08% | 112 | 1.01% | 157 | 16.30% | 76 | -9.52% |
Mar 31, 2024 | 280 | 4.87% | 48,943,510 | 1.26% | 105 | 0.97% | 135 | 4.65% | 84 | -5.62% |
Dec 31, 2023 | 267 | 1.52% | 48,335,779 | 2.87% | 104 | 1.02% | 129 | -3.73% | 89 | 5.95% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Pacer US Small Cap Cash Cows 100 ETF | 3.07M | 6.65% | -6.23K |
iShares Core S&P Small-Cap ETF | 2.98M | 6.44% | 9.53K |
Vanguard Total Stock Mkt Idx Inv | 1.38M | 2.98% | - |
Delaware Small Cap Core I | 1.26M | 2.74% | -18.77K |
iShares Russell 2000 ETF | 1.25M | 2.70% | -9.45K |
Vanguard Small Cap Index | 1.12M | 2.42% | 9.89K |
Stephens SMID Select Growth | 863.32K | 1.87% | -4.92K |
Vanguard Small Cap Value Index Inv | 741.59K | 1.61% | -4.81K |
Vanguard Institutional Extnd Mkt Idx Tr | 692.89K | 1.50% | -23.23K |
Vanguard Explorer Inv | 673.57K | 1.46% | -4.72K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 06, 2025 | SLONIN JONATHAN | Chief Medical Officer | Sell | $16.17K |
Dec 13, 2024 | GAUGLER DARYL | Chief Operating Officer | Sell | $9.88K |
Sep 13, 2024 | GAUGLER DARYL | Chief Operating Officer | Sell | $6.43K |
Aug 16, 2024 | BIGAL MARCELO | - | Buy | $20.03K |
Aug 16, 2024 | Brege Laura | - | Buy | $12.81K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 1 |
2024 Q4 | - | 1 |
2024 Q3 | 6 | 3 |
2024 Q2 | - | 5 |
2024 Q1 | - | 3 |
PCRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools